rs200075643
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BS2_SupportingBA1
This summary comes from the ClinGen Evidence Repository: NM_000215.4(JAK3):c.1843C>T (p.Arg615Cys) is a missense variant predicted to cause substitution of Arginine by Cysteine at amino acid 615.The filtering allele frequency (the upper threshold of the 95% CI of 534/91086) of the c.1843C>T variant in JAK3 is 0.005451 for South Asian chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00447) for BA1 and therefore meets this criterion (BA1). Additionally, 5 adult homozygous occurrences are reported in gnomAD v4 (BS2_Supporting).In summary, this variant meets the criteria to be classified as a Benign variant for autosomal recessive severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 and BS2_Supporting (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA160213/MONDO:0010938/121
Frequency
Consequence
NM_000215.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK3 | NM_000215.4 | c.1843C>T | p.Arg615Cys | missense_variant | 14/24 | ENST00000458235.7 | NP_000206.2 | |
JAK3 | XM_047438786.1 | c.1843C>T | p.Arg615Cys | missense_variant | 14/24 | XP_047294742.1 | ||
JAK3 | XR_007066796.1 | n.1893C>T | non_coding_transcript_exon_variant | 14/20 | ||||
JAK3 | XM_011527991.3 | c.*922C>T | downstream_gene_variant | XP_011526293.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAK3 | ENST00000458235.7 | c.1843C>T | p.Arg615Cys | missense_variant | 14/24 | 5 | NM_000215.4 | ENSP00000391676.1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000784 AC: 197AN: 251304Hom.: 3 AF XY: 0.00102 AC XY: 139AN XY: 135850
GnomAD4 exome AF: 0.000371 AC: 542AN: 1461804Hom.: 5 Cov.: 32 AF XY: 0.000514 AC XY: 374AN XY: 727192
GnomAD4 genome AF: 0.000204 AC: 31AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74492
ClinVar
Submissions by phenotype
T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:3
Benign, reviewed by expert panel | curation | ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen | Apr 03, 2024 | NM_000215.4(JAK3):c.1843C>T (p.Arg615Cys) is a missense variant predicted to cause substitution of Arginine by Cysteine at amino acid 615. The filtering allele frequency (the upper threshold of the 95% CI of 534/91086) of the c.1843C>T variant in JAK3 is 0.005451 for South Asian chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00447) for BA1 and therefore meets this criterion (BA1). Additionally, 5 adult homozygous occurrences are reported in gnomAD v4 (BS2_Supporting). In summary, this variant meets the criteria to be classified as a Benign variant for autosomal recessive severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 and BS2_Supporting (VCEP specifications version 1). - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
JAK3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 17, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at